Global Geriatric Medicines Market Research Report 2023

Report ID: 1897826 | Published Date: Sep 2024 | No. of Page: 93 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Geriatric Medicines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Analgesics
        1.2.3 Antihypertensives
        1.2.4 Statins
        1.2.5 Antidiabetics
        1.2.6 Proton Pump Inhibitor
        1.2.7 Anticoagulant
        1.2.8 Antipsychotics
        1.2.9 Antidepressants
    1.3 Market by Application
        1.3.1 Global Geriatric Medicines Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Cardiovascular diseases
        1.3.3 Arthritis
        1.3.4 Neurological Disorders
        1.3.5 Cancer
        1.3.6 Osteoporosis
        1.3.7 Respiratory
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Geriatric Medicines Market Perspective (2017-2028)
    2.2 Geriatric Medicines Growth Trends by Region
        2.2.1 Geriatric Medicines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Geriatric Medicines Historic Market Size by Region (2017-2022)
        2.2.3 Geriatric Medicines Forecasted Market Size by Region (2023-2028)
    2.3 Geriatric Medicines Market Dynamics
        2.3.1 Geriatric Medicines Industry Trends
        2.3.2 Geriatric Medicines Market Drivers
        2.3.3 Geriatric Medicines Market Challenges
        2.3.4 Geriatric Medicines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Geriatric Medicines Players by Revenue
        3.1.1 Global Top Geriatric Medicines Players by Revenue (2017-2022)
        3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2017-2022)
    3.2 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Geriatric Medicines Revenue
    3.4 Global Geriatric Medicines Market Concentration Ratio
        3.4.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2021
    3.5 Geriatric Medicines Key Players Head office and Area Served
    3.6 Key Players Geriatric Medicines Product Solution and Service
    3.7 Date of Enter into Geriatric Medicines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicines Breakdown Data by Type
    4.1 Global Geriatric Medicines Historic Market Size by Type (2017-2022)
    4.2 Global Geriatric Medicines Forecasted Market Size by Type (2023-2028)
5 Geriatric Medicines Breakdown Data by Application
    5.1 Global Geriatric Medicines Historic Market Size by Application (2017-2022)
    5.2 Global Geriatric Medicines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Geriatric Medicines Market Size (2017-2028)
    6.2 North America Geriatric Medicines Market Size by Country (2017-2022)
    6.3 North America Geriatric Medicines Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Geriatric Medicines Market Size (2017-2028)
    7.2 Europe Geriatric Medicines Market Size by Country (2017-2022)
    7.3 Europe Geriatric Medicines Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Geriatric Medicines Market Size (2017-2028)
    8.2 Asia-Pacific Geriatric Medicines Market Size by Country (2017-2022)
    8.3 Asia-Pacific Geriatric Medicines Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Geriatric Medicines Market Size (2017-2028)
    9.2 Latin America Geriatric Medicines Market Size by Country (2017-2022)
    9.3 Latin America Geriatric Medicines Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Geriatric Medicines Market Size (2017-2028)
    10.2 Middle East & Africa Geriatric Medicines Market Size by Country (2017-2022)
    10.3 Middle East & Africa Geriatric Medicines Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eli Lilly and Company
        11.1.1 Eli Lilly and Company Company Detail
        11.1.2 Eli Lilly and Company Business Overview
        11.1.3 Eli Lilly and Company Geriatric Medicines Introduction
        11.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2017-2022)
        11.1.5 Eli Lilly and Company Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Detail
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Geriatric Medicines Introduction
        11.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2017-2022)
        11.2.5 AstraZeneca Recent Development
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Detail
        11.3.2 Boehringer Ingelheim Business Overview
        11.3.3 Boehringer Ingelheim Geriatric Medicines Introduction
        11.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2017-2022)
        11.3.5 Boehringer Ingelheim Recent Development
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Detail
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Geriatric Medicines Introduction
        11.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2017-2022)
        11.4.5 Abbott Laboratories Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Detail
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Geriatric Medicines Introduction
        11.5.4 Sanofi Revenue in Geriatric Medicines Business (2017-2022)
        11.5.5 Sanofi Recent Development
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Detail
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2017-2022)
        11.6.5 Bristol-Myers Squibb Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Geriatric Medicines Introduction
        11.7.4 Merck Revenue in Geriatric Medicines Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Geriatric Medicines Introduction
        11.8.4 Novartis Revenue in Geriatric Medicines Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Geriatric Medicines Introduction
        11.9.4 Pfizer Revenue in Geriatric Medicines Business (2017-2022)
        11.9.5 Pfizer Recent Development
    11.10 GSK
        11.10.1 GSK Company Detail
        11.10.2 GSK Business Overview
        11.10.3 GSK Geriatric Medicines Introduction
        11.10.4 GSK Revenue in Geriatric Medicines Business (2017-2022)
        11.10.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Geriatric Medicines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Analgesics
    Table 3. Key Players of Antihypertensives
    Table 4. Key Players of Statins
    Table 5. Key Players of Antidiabetics
    Table 6. Key Players of Proton Pump Inhibitor
    Table 7. Key Players of Anticoagulant
    Table 8. Key Players of Antipsychotics
    Table 9. Key Players of Antidepressants
    Table 10. Global Geriatric Medicines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Geriatric Medicines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Geriatric Medicines Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Geriatric Medicines Market Share by Region (2017-2022)
    Table 14. Global Geriatric Medicines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Geriatric Medicines Market Share by Region (2023-2028)
    Table 16. Geriatric Medicines Market Trends
    Table 17. Geriatric Medicines Market Drivers
    Table 18. Geriatric Medicines Market Challenges
    Table 19. Geriatric Medicines Market Restraints
    Table 20. Global Geriatric Medicines Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Geriatric Medicines Market Share by Players (2017-2022)
    Table 22. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2021)
    Table 23. Ranking of Global Top Geriatric Medicines Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Geriatric Medicines Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Geriatric Medicines Product Solution and Service
    Table 27. Date of Enter into Geriatric Medicines Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Geriatric Medicines Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Geriatric Medicines Revenue Market Share by Type (2017-2022)
    Table 31. Global Geriatric Medicines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Geriatric Medicines Revenue Market Share by Type (2023-2028)
    Table 33. Global Geriatric Medicines Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Geriatric Medicines Revenue Market Share by Application (2017-2022)
    Table 35. Global Geriatric Medicines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Geriatric Medicines Revenue Market Share by Application (2023-2028)
    Table 37. North America Geriatric Medicines Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Geriatric Medicines Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Geriatric Medicines Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Europe Geriatric Medicines Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Asia-Pacific Geriatric Medicines Market Size by Region (2017-2022) & (US$ Million)
    Table 42. Asia-Pacific Geriatric Medicines Market Size by Region (2023-2028) & (US$ Million)
    Table 43. Latin America Geriatric Medicines Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Latin America Geriatric Medicines Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Middle East & Africa Geriatric Medicines Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Middle East & Africa Geriatric Medicines Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Eli Lilly and Company Company Detail
    Table 48. Eli Lilly and Company Business Overview
    Table 49. Eli Lilly and Company Geriatric Medicines Product
    Table 50. Eli Lilly and Company Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 51. Eli Lilly and Company Recent Development
    Table 52. AstraZeneca Company Detail
    Table 53. AstraZeneca Business Overview
    Table 54. AstraZeneca Geriatric Medicines Product
    Table 55. AstraZeneca Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 56. AstraZeneca Recent Development
    Table 57. Boehringer Ingelheim Company Detail
    Table 58. Boehringer Ingelheim Business Overview
    Table 59. Boehringer Ingelheim Geriatric Medicines Product
    Table 60. Boehringer Ingelheim Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 61. Boehringer Ingelheim Recent Development
    Table 62. Abbott Laboratories Company Detail
    Table 63. Abbott Laboratories Business Overview
    Table 64. Abbott Laboratories Geriatric Medicines Product
    Table 65. Abbott Laboratories Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 66. Abbott Laboratories Recent Development
    Table 67. Sanofi Company Detail
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Geriatric Medicines Product
    Table 70. Sanofi Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 71. Sanofi Recent Development
    Table 72. Bristol-Myers Squibb Company Detail
    Table 73. Bristol-Myers Squibb Business Overview
    Table 74. Bristol-Myers Squibb Geriatric Medicines Product
    Table 75. Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 76. Bristol-Myers Squibb Recent Development
    Table 77. Merck Company Detail
    Table 78. Merck Business Overview
    Table 79. Merck Geriatric Medicines Product
    Table 80. Merck Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 81. Merck Recent Development
    Table 82. Novartis Company Detail
    Table 83. Novartis Business Overview
    Table 84. Novartis Geriatric Medicines Product
    Table 85. Novartis Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 86. Novartis Recent Development
    Table 87. Pfizer Company Detail
    Table 88. Pfizer Business Overview
    Table 89. Pfizer Geriatric Medicines Product
    Table 90. Pfizer Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 91. Pfizer Recent Development
    Table 92. GSK Company Detail
    Table 93. GSK Business Overview
    Table 94. GSK Geriatric Medicines Product
    Table 95. GSK Revenue in Geriatric Medicines Business (2017-2022) & (US$ Million)
    Table 96. GSK Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Geriatric Medicines Market Share by Type: 2021 VS 2028
    Figure 2. Analgesics Features
    Figure 3. Antihypertensives Features
    Figure 4. Statins Features
    Figure 5. Antidiabetics Features
    Figure 6. Proton Pump Inhibitor Features
    Figure 7. Anticoagulant Features
    Figure 8. Antipsychotics Features
    Figure 9. Antidepressants Features
    Figure 10. Global Geriatric Medicines Market Share by Application in 2021 & 2028
    Figure 11. Cardiovascular diseases Case Studies
    Figure 12. Arthritis Case Studies
    Figure 13. Neurological Disorders Case Studies
    Figure 14. Cancer Case Studies
    Figure 15. Osteoporosis Case Studies
    Figure 16. Respiratory Case Studies
    Figure 17. Geriatric Medicines Report Years Considered
    Figure 18. Global Geriatric Medicines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 19. Global Geriatric Medicines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Geriatric Medicines Market Share by Region: 2021 VS 2028
    Figure 21. Global Geriatric Medicines Market Share by Players in 2021
    Figure 22. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by Geriatric Medicines Revenue in 2021
    Figure 24. North America Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. North America Geriatric Medicines Market Share by Country (2017-2028)
    Figure 26. United States Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Canada Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Europe Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Europe Geriatric Medicines Market Share by Country (2017-2028)
    Figure 30. Germany Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Geriatric Medicines Market Share by Region (2017-2028)
    Figure 38. China Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Latin America Geriatric Medicines Market Share by Country (2017-2028)
    Figure 46. Mexico Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Geriatric Medicines Market Share by Country (2017-2028)
    Figure 50. Turkey Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Geriatric Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Eli Lilly and Company Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 53. AstraZeneca Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 54. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 55. Abbott Laboratories Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 58. Merck Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 61. GSK Revenue Growth Rate in Geriatric Medicines Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Frequently Asked Questions
Geriatric Medicines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Geriatric Medicines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Geriatric Medicines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

HAIs Control

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Healthcare Analytics

Healthcare Analytics market is segmented by players, region (country), by Type and by Application ... Read More